The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Boston Scientific
Pertuzumab plus trastuzumab (P+T) in patients (Pts) with uterine cancer (UC) with ERBB2 or ERBB3 amplification, overexpression or mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
 
Hussein Moustapha Ali-Ahmad
No Relationships to Disclose
 
Michael Rothe
Research Funding - Eisai; Pfizer
 
Pam K. Mangat
No Relationships to Disclose
 
Liz Garrett-Mayer
Consulting or Advisory Role - Deciphera; TYME
 
Eugene Ahn
Employment - Cancer Treament Centers of America
Leadership - Cancer Treament Centers of America
 
John Chan
Honoraria - AstraZeneca; Clovis Oncology; Genentech/Roche; Merck; Tesaro
Consulting or Advisory Role - Abbvie; Agenus; Clovis Oncology; Eisai; Genentech/Roche; Seagen; Tesaro/GSK; Vaniam Group
Speakers' Bureau - AstraZeneca; Clovis Oncology; Genentech/Roche; Merck; Tesaro/GSK
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Genentech/Roche; Merck; Tesaro/GSK
 
Michael L. Maitland
Consulting or Advisory Role - Acceleron Pharma (I); Actelion/Janssen (I); Gossamer Bio (I); Reata Pharmaceuticals (I); United Therapeutics (I)
Research Funding - AstraZeneca (Inst); Pfizer (Inst)
 
Ani Sarkis Balmanoukian
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Genentech; Merck
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Genentech/Roche (Inst); incyte (Inst); Merck (Inst); Seagen (Inst)
 
Sapna R. Patel
No Relationships to Disclose
 
Zachary Reese
No Relationships to Disclose
 
Charles W. Drescher
No Relationships to Disclose
 
Charles A. Leath
Consulting or Advisory Role - Abbvie; Clovis Oncology; Eisai; GlaxoSmithKline; Seagen
Research Funding - Abbvie (Inst); Agenus (Inst); AstraZeneca (Inst); Celsion (Inst); Corcept Therapeutics (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Eisai
 
Rui Li
No Relationships to Disclose
 
Apostolia Maria Tsimberidou
Consulting or Advisory Role - Tempus
Research Funding - Agenus (Inst); Boston Biomedical (Inst); IMMATICS (Inst); Karus Therapeutics (Inst); OBI Pharma (Inst); Parker Institute for Cancer Immunotherapy (Inst); Placon (Inst); Stem Cells, Inc. (Inst); Tempus (Inst)
Travel, Accommodations, Expenses - Japanese Society of Clinical Oncology
 
Richard L. Schilsky
Consulting or Advisory Role - Cellworks; Scandion Oncology
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)